![]() |
![]() |
||||||
![]() |
![]() |
||||||
![]() |
||||||
Animas Corporation (Medical Devices – insulin pumps for the diabetes market, acquired by Johnson & Johnson) |
Private Equity* |
|||||
Carter-Wallace, Inc. (Specialty Pharma, acquired by MedPointe |
M&A Advisory |
|||||
Gentium S.p.A. (Biotechnology – treatment of vascular disease and oncology-related conditions) NASDAQ:GENT |
M&A Advisory/ PIPE |
|||||
Kos Pharmaceuticals, Inc. (Specialty Pharma – cardiovascular, acquired by Abbott Laboratories) |
IPO/ M&A Advisory |
|||||
Medicis Pharmaceutical Corp. (Specialty Pharma – dermatology) |
M&A Advisory |
|||||
NMT Medical, Inc. (Medical Devices – minimally invasive solutions for the treatment of cardiac sources of stroke) NASDAQ:NMTI |
Private Equity*/ M&A Advisory |
|||||
Afferon Corporation (Specialty Pharma – urology) |
M&A Advisory |
|||||
DentalXChange, Inc. (Online Dental Services, acquired by MetLife) |
Private Equity |
|||||
Endius Inc. (Medical Devices – minimally-invasive spine surgery, acquired by Zimmer Holdings) |
Private Equity |
|||||
Integrity Pharmaceutical Corporation (Specialty Pharma – women's health, merged with Xanodyne Pharmaceuticals) |
M&A Advisory |
|||||
Richwood Pharmaceutical Company (Specialty Pharma–ADHD drug ADDERALL®, acquired by Shire Pharmaceuticals) |
M&A Advisory |
|||||
SCIREX Corporation (CRO, acquired by Omnicom) |
Private Equity/ M&A Advisory |
|||||
UtiliMED, Inc. (Radiology Services, acquired by American Imaging |
M&A Advisory |
|||||
* While private. |
||||||